Changes in health in the countries of the UK and 150 English Local Authority areas 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016

Nicholas Steel, John A Ford, John N Newton, Adrian C J Davis, Theo Vos, Mohsen Naghavi, Scott Glenn, Andrew Hughes, Alice M Dalton, Diane Stockton, Ciaran Humphreys, Mary Dallat, Jürgen Schmidt, Julian Flowers, Sebastian Fox, Ibrahim Abubakar, Robert W Aldridge, Allan Baker, Carol Brayne, Traolach Brugha, Simon Capewell, Josip Car, Cyrus Cooper, Majid Ezzati, Justine Fitzpatrick, Felix Greaves, Roderick Hay, Simon Hay, Frank Kee, Heidi J Larson, Ronan A Lyons, Azeem Majeed, Martin McKee, Salman Rawaf, Harry Rutter, Sonia Saxena, Aziz Sheikh, Liam Smeeth, Russell M Viner, Stein Emil Vollset, Hywel C Williams, Charles Wolfe, Anthony Woolf, Christopher J L Murray, Nicholas Steel, John A Ford, John N Newton, Adrian C J Davis, Theo Vos, Mohsen Naghavi, Scott Glenn, Andrew Hughes, Alice M Dalton, Diane Stockton, Ciaran Humphreys, Mary Dallat, Jürgen Schmidt, Julian Flowers, Sebastian Fox, Ibrahim Abubakar, Robert W Aldridge, Allan Baker, Carol Brayne, Traolach Brugha, Simon Capewell, Josip Car, Cyrus Cooper, Majid Ezzati, Justine Fitzpatrick, Felix Greaves, Roderick Hay, Simon Hay, Frank Kee, Heidi J Larson, Ronan A Lyons, Azeem Majeed, Martin McKee, Salman Rawaf, Harry Rutter, Sonia Saxena, Aziz Sheikh, Liam Smeeth, Russell M Viner, Stein Emil Vollset, Hywel C Williams, Charles Wolfe, Anthony Woolf, Christopher J L Murray

Abstract

Background: Previous studies have reported national and regional Global Burden of Disease (GBD) estimates for the UK. Because of substantial variation in health within the UK, action to improve it requires comparable estimates of disease burden and risks at country and local levels. The slowdown in the rate of improvement in life expectancy requires further investigation. We use GBD 2016 data on mortality, causes of death, and disability to analyse the burden of disease in the countries of the UK and within local authorities in England by deprivation quintile.

Methods: We extracted data from the GBD 2016 to estimate years of life lost (YLLs), years lived with disability (YLDs), disability-adjusted life-years (DALYs), and attributable risks from 1990 to 2016 for England, Scotland, Wales, Northern Ireland, the UK, and 150 English Upper-Tier Local Authorities. We estimated the burden of disease by cause of death, condition, year, and sex. We analysed the association between burden of disease and socioeconomic deprivation using the Index of Multiple Deprivation. We present results for all 264 GBD causes of death combined and the leading 20 specific causes, and all 84 GBD risks or risk clusters combined and 17 specific risks or risk clusters.

Findings: The leading causes of age-adjusted YLLs in all UK countries in 2016 were ischaemic heart disease, lung cancers, cerebrovascular disease, and chronic obstructive pulmonary disease. Age-standardised rates of YLLs for all causes varied by two times between local areas in England according to levels of socioeconomic deprivation (from 14 274 per 100 000 population [95% uncertainty interval 12 791-15 875] in Blackpool to 6888 [6145-7739] in Wokingham). Some Upper-Tier Local Authorities, particularly those in London, did better than expected for their level of deprivation. Allowing for differences in age structure, more deprived Upper-Tier Local Authorities had higher attributable YLLs for most major risk factors in the GBD. The population attributable fractions for all-cause YLLs for individual major risk factors varied across Upper-Tier Local Authorities. Life expectancy and YLLs have improved more slowly since 2010 in all UK countries compared with 1990-2010. In nine of 150 Upper-Tier Local Authorities, YLLs increased after 2010. For attributable YLLs, the rate of improvement slowed most substantially for cardiovascular disease and breast, colorectal, and lung cancers, and showed little change for Alzheimer's disease and other dementias. Morbidity makes an increasing contribution to overall burden in the UK compared with mortality. The age-standardised UK DALY rate for low back and neck pain (1795 [1258-2356]) was higher than for ischaemic heart disease (1200 [1155-1246]) or lung cancer (660 [642-679]). The leading causes of ill health (measured through YLDs) in the UK in 2016 were low back and neck pain, skin and subcutaneous diseases, migraine, depressive disorders, and sense organ disease. Age-standardised YLD rates varied much less than equivalent YLL rates across the UK, which reflects the relative scarcity of local data on causes of ill health.

Interpretation: These estimates at local, regional, and national level will allow policy makers to match resources and priorities to levels of burden and risk factors. Improvement in YLLs and life expectancy slowed notably after 2010, particularly in cardiovascular disease and cancer, and targeted actions are needed if the rate of improvement is to recover. A targeted policy response is also required to address the increasing proportion of burden due to morbidity, such as musculoskeletal problems and depression. Improving the quality and completeness of available data on these causes is an essential component of this response.

Funding: Bill & Melinda Gates Foundation and Public Health England.

Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Figures

Figure 1
Figure 1
Age-standardised YLL, YLD, and DALY rates per 100 000 population for all causes combined and leading ten causes in UK countries, women, men, and both sexes, 2016 YLLs=years of life lost. YLDs=years lived with disability. DALY=disability-adjusted life-year.
Figure 1
Figure 1
Age-standardised YLL, YLD, and DALY rates per 100 000 population for all causes combined and leading ten causes in UK countries, women, men, and both sexes, 2016 YLLs=years of life lost. YLDs=years lived with disability. DALY=disability-adjusted life-year.
Figure 2
Figure 2
PAF for risk factors for all-cause YLLs rate per 100 000 population for England, Scotland, Wales, and Northern Ireland, both sexes, 2016 PAF=population attributable fraction. YLLs=years of life lost.
Figure 3
Figure 3
All-cause age-standardised YLL and YLD rates per 100 000 population by UK country and English Upper Tier Local Authorities, 2016 YLLs=years of life lost. YLDs=years lived with disability.
Figure 4
Figure 4
Age-standardised YLL rate per 100 000 people for the 20 causes with the highest national YLL burden (order of decreasing burden), in the 15 (10%) most deprived, and 15 (10%) least deprived UTLAs in England, both sexes, 2016 YLLs=years of life lost. UTLAs=Upper-Tier Local Authorities. IMD=Index of Multiple Deprivation. UI=uncertainty interval. NA=not applicable.
Figure 5
Figure 5
Age-standardised YLD rate per 100 000 population for the 20 causes with the highest national YLD burden (order of decreasing burden), in the 15 (10%) most deprived, and 15 (10%) least deprived UTLAs in England, both sexes, 2016 No estimates were significantly different from the mean for England. YLDs=years lived with disability. UTLAs=Upper-Tier Local Authorities. IMD=Index of Multiple Deprivation. UI=uncertainty interval. NA=not applicable.
Figure 6
Figure 6
Attributable risk for age-standardised all-cause YLL rate per 100 000 population for nine major risk factors, and UTLA level IMD score, for UTLAs in three regions of England, 2016 YLL=years of life lost. UTLAs=Upper-Tier Local Authorities. IMD=Index of Multiple Deprivation.
Figure 7
Figure 7
Life expectancy at birth for England, Scotland, Wales, and Northern Ireland 1990–2016, by sex
Figure 8
Figure 8
Annual percentage change in YLL rate per 100 000 people for the nine causes with the highest national burden, 1990–2016 in England Ribbons are 95% uncertainty intervals. The percentage contribution of each condition to all-cause YLLs is given in brackets. YLLs=years of life lost.

References

    1. Murray CJL, Lopez AD. Measuring global health: motivation and evolution of the Global Burden of Disease Study. Lancet. 2017;390:1460–1464.
    1. Wang H, Abajobir AA, Abate KH. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1084–1150.
    1. Naghavi M, Abajobir AA, Abbafati C. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1151–1210.
    1. Vos T, Abajobir AA, Abate KH. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1211–1259.
    1. Hay SI, Abajobir AA, Abate KH. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1260–1344.
    1. Gakidou E, Afshin A, Abajobir AA. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1345–1422.
    1. Fullman N, Barber RM, Abajobir AA. Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016. Lancet. 2017;390:1423–1459.
    1. Bloomberg MR. Annual letter on philanthropy 2017. 2017.
    1. FiA Foundation Step change: an action agenda on safe walking for Africa's children. 2017.
    1. Murray CJL, Richards MA, Newton JN. UK health performance: findings of the Global Burden of Disease Study 2010. Lancet. 2013;381:997–1020.
    1. Newton JN, Briggs ADM, Murray CJL. Changes in health in England, with analysis by English regions and areas of deprivation, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386:2257–2274.
    1. Public Health England Health profile for England. 2017.
    1. Public Health Wales Observatory Health and its determinants in Wales. Informing strategic planning report. 2018.
    1. Chinnery F, Bashevoy G, Blatch-Jones A, Douet L, Puddicombe S, Raftery J. National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme research funding and UK burden of disease. Trials. 2018;19:87.
    1. Crispe A. Using the Global Burden of Disease Study to understand local health needs, Suffolk County Council. 2017.
    1. Scottish Burden of Disease Team The Scottish Burden of Disease Study, 2015. Overview report. 2017.
    1. Institute of Health Metrics and Evaluation Independent Advisory Committee Meetings. 2017.
    1. Nomura S, Sakamoto H, Glenn S. Population health and regional variations of disease burden in Japan, 1990–2015: a systematic subnational analysis for the Global Burden of Disease Study 2015. Lancet. 2017;390:1521–1538.
    1. Dandona L, Dandona R, Kumar GA. Nations within a nation: variations in epidemiological transition across the states of India, 1990–2016 in the Global Burden of Disease Study. Lancet. 2017;390:2437–2460.
    1. Greer SL. Devolution and health in the UK: policy and its lessons since 1998. Br Med Bull. 2016;118:16–24.
    1. Office for National Statistics Population estimates—local authority based by single year of age, mid-2016. 2018.
    1. Hiam L, Dorling D, Harrison D, McKee M. Why has mortality in England and Wales been increasing? An iterative demographic analysis. J Royal Soc Med. 2017;110:153–162.
    1. Watkins J, Wulaningsih W, Da Zhou C. Effects of health and social care spending constraints on mortality in England: a time trend analysis. BMJ Open. 2017;7:e017722.
    1. Institute of Health Metrics and Evaluation Global Burden of Disease Study 2016 (GBD 2016) Data Input Sources Tool. 2018.
    1. Flaxman ADVT, Murray CJL. University of Washington Press; Seattle, WA: 2015. An integrative metaregression framework for descriptive epidemiology.
    1. University of Edinburgh Census support digitised boundary data, 1840– and postcode directories. 1980–2017.
    1. Environmental Systems Research Institute ArcGIS 10.4.12016.
    1. Smith T, Noble M, Noble S, Wright G, McLennan D, Plunkett E. Department for Communities and Local Government; London: 2015. The English indices of deprivation 2015: technical report.
    1. National Records of Scotland . National Records of Scotland; Edinburgh: 2017. Life expectancy for areas within Scotland 2014–2016.
    1. Bunting BP, Murphy SD, O'Neill SM, Ferry FR. Lifetime prevalence of mental health disorders and delay in treatment following initial onset: evidence from the Northern Ireland Study of Health and Stress. Psychol Med. 2012;42:1727–1739.
    1. Benson T, O'Neill S, Murphy S, Ferry F, Bunting B. Prevalence and predictors of psychotropic medication use: results from the Northern Ireland Study of Health and Stress. Epidemiol Psychiatr Sci. 2015;24:542–552.
    1. Barnes A, Baxter S, Beynon C. Association of the Directors of Public Health (ADPH); 2018. Four Nations Study: a comparative systems review and thematic policy analysis of public health across the four constituent countries of the UK.
    1. Barr B, Higgerson J, Whitehead M. Investigating the impact of the English health inequalities strategy: time trend analysis. BMJ. 2017;358:j3310.
    1. Bevan G, Karanikolos M, Exley J, Nolte E, Connolly S, Mays N. Nuffield Trust and Health Foundation; London: 2014. The four health systems of the UK: How do they compare? Research report.
    1. Nuffield Trust Health spending per head: UK countries. 2018.
    1. Mesalles-Naranjo O, Grant I, Wyper GMA. Trends and inequalities in the burden of mortality in Scotland 2000–2015. PLoS One. 2018;13:e0196906.
    1. Grant I, Mesalles-Naranjo O, Wyper G. Burden of disease in Scotland: invited chapter. In: Slater Anne., editor. Scotland's population, the registrar general's annual review of demographic trends 2017. National Records of Scotland; Edinburgh: 2018.
    1. Capewell S, O'Flaherty M. Rapid mortality falls after risk-factor changes in populations. Lancet. 2011;378:752–753.
    1. McCarthy M. Will Public Health England lead research? Lancet. 2015;386:2232–2234.
    1. Blanden J, Greaves E, Gregg P, Macmillan L, Sibieta L. Understanding the improved performance of disadvantaged pupils in London. Working paper 21: The London School of Economics and Political Science. 2015.
    1. Kontopantelis E, Mamas MA, van Marwijk H. Chronic morbidity, deprivation and primary medical care spending in England in 2015–16: a cross-sectional spatial analysis. BMC Med. 2018;16:19.
    1. Whitehead M. Due North. Report of the Inquiry on Health Equity for the North. 2014.
    1. Buchan IE, Kontopantelis E, Sperrin M, Chandola T, Doran T. North-south disparities in English mortality 1965–2015: longitudinal population study. J Epidemiol Community Health. 2017;71:928–936.
    1. Katikireddi SV, Cezard G, Bhopal RS. Assessment of health care, hospital admissions, and mortality by ethnicity: population-based cohort study of health-system performance in Scotland. Lancet Public Health. 2018;3:e226–ee36.
    1. Office for National Statistics . Office for National Statistics; London: 2018. Changing trends in mortality: a cross-UK comparison, 1981 to 2016.
    1. Office for National Statistics Child mortality in England and Wales: 2016. 2018.
    1. Baker A, Ege F, Fitzpatrick J, Newton J. Response to articles on mortality in England and Wales. J R Soc Med. 2018;111:40–41.
    1. Raleigh V. Why have improvements in mortality slowed down? 2017.
    1. Childs A, Dring A, Lester N, Little K. Public Health Wales Observatory; Cardiff: 2018. Mortality in Wales 2002 to 2016.
    1. Allemani C, Matsuda T, Di Carlo V. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37,513,025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391:1023–1075.
    1. The Marmot Review Fair society, healthy lives. Strategic review of health inequalities in England post-2010. 2010.
    1. Buck D, Maguire D. Inequalities in life expectancy: changes over time and implications for policy. 2015.
    1. Mallon E, Newton J, Klassen A, Stewart-Brown SL, Ryan TJ, Finlay AY. The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br J Dermatol. 1999;140:672–676.
    1. National Cancer Registration and Analysis Service. Public Health England Deprivation and cancer: in search of a common measure across England, Wales, Scotland, Northern Ireland and Ireland. Based on cancer incidence and mortality data, 2008–2012. 2016.
    1. Dalton JE, Perzynski AT, Zidar DA. Accuracy of cardiovascular risk prediction varies by neighborhood socioeconomic position: a retrospective cohort study. Ann Intern Med. 2017;167:456–464.
    1. NHS Digital Quality and Outcomes Framework (QOF) business rules. 2018.
    1. NHS Digital Health Survey for England: health, social care and lifestyles. 2018.
    1. Sharma M, Nazareth I, Petersen I. Trends in incidence, prevalence and prescribing in type 2 diabetes mellitus between 2000 and 2013 in primary care: a retrospective cohort study. BMJ Open. 2016;6:e010210.
    1. Ford ES, Capewell S. Proportion of the decline in cardiovascular mortality disease due to prevention versus treatment: public health versus clinical care. Annu Rev Public Health. 2011;32:5–22.
    1. WHO Regional Office for Europe Action plan for the prevention and control of noncommunicable diseases in the WHO European region. 2016.
    1. Morgan M, Mays N, Holland WW. Can hospital use be a measure of need for health care? J Epidemiol Community Health. 1987;41:269–274.
    1. Stein C, Newton J. Sharing the burden: a new European Burden of Disease Network is formed. Eur J Public Health. 2017;27:191–192.

Source: PubMed

3
Abonnieren